Get the Stockscreener App
5.49
1.48%
0.08
Chromadex Corp Stock (CDXC) Forecast
The Chromadex Corp (CDXC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.0923, representing a -43.67% decrease from the current price of $5.49. The highest analyst price target is $3.5527, and the lowest is $2.6318.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDXC Price Target
Average 3.1622
(-42.40% Downside)
Is Chromadex Corp (CDXC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.96 | Neutral |
| STOCH(9,6) | 6.2243 | Buy |
| STOCHRSI(14) | 5.1315 | Buy |
| MACD(12,26) | -0.1717 | Sell |
| ADX(14) | 33.63 | Sell |
| William %R | -90.54 | Buy |
| CCI(14) | -96.49 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.101
Sell
|
6.0513
Sell
|
| MA20 |
6.747
Sell
|
6.3341
Sell
|
| MA50 |
5.812
Sell
|
5.8797
Sell
|
| MA100 |
4.5692
Buy
|
5.02
Buy
|
| MA200 |
3.8612
Buy
|
3.9946
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CDXC could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CDXC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.96 indicates that CDXC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 6.2243 indicates that CDXC is oversold. This indicates that CDXC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.1315 indicates that CDXC is oversold. This suggests that CDXC price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.63 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -96.49 indicates that CDXC is still oversold but not to an extreme extent.
Long-term CDXC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Chromadex Corp financial reports and earnings history, Chromadex Corp (CDXC) stock could reach $2.6519 by 2030, $1.3891 by 2040 and $2.2381 by 2050. See the projected annual prices until 2050 of the Chromadex Corp stock below:
- Chromadex Corp (CDXC) is expected to reach an average price of $0.2725 in 2035, with a high prediction of $0.4899 and a low estimate of $0.4025. This indicates an $-95.04% rise from the last recorded price of $5.49.
- Chromadex Corp (CDXC) stock is projected to chart a bullish course in 2040, with an average price target of $1.4791, representing an $-73.06% surge from its current level. The forecast ranges from a conservative $1.3775 to a sky-high $1.3891.
- Our analysts predict Chromadex Corp (CDXC) to jump -53.09% by 2045, soaring from $2.4668 to an average price of $2.5756, potentially reaching $2.4993. While $2.4668 is the low estimate, the potential upside is significant.
- Chromadex Corp (CDXC) stock is expected to climb by 2050, reaching an average of $2.3638, a $-56.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.2381 and $2.3978, respectively, highlighting the market's uncertainty.
Chromadex Corp Stock (CDXC) Year by Year Forecast
Chromadex Corp Stock (CDXC) Price Forecast for 2025
Chromadex Corp Stock (CDXC) is expected to reach an average price of $3.1622 in 2025, with a high prediction of $4.9276 and a low estimate of $1.3968. This indicates an -42.40% fall from the last recorded price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.2755 | $2.6318 | $3.5527 | -40.34% |
| February, 2025 | $3.2293 | $2.9083 | $3.6865 | -41.18% |
| March, 2025 | $2.473 | $2.093 | $3.2962 | -54.95% |
| April, 2025 | $2.1577 | $1.3968 | $2.6549 | -60.70% |
| May, 2025 | $3.0014 | $1.8486 | $3.6214 | -45.33% |
| June, 2025 | $3.5052 | $3.2952 | $4.7042 | -36.15% |
| July, 2025 | $3.5199 | $2.8189 | $3.902 | -35.89% |
| August, 2025 | $4.0136 | $3.2017 | $4.4636 | -26.89% |
| September, 2025 | $3.8923 | $3.7173 | $4.3245 | -29.10% |
| October, 2025 | $3.442 | $3.327 | $4.6492 | -37.30% |
| November, 2025 | $2.9358 | $2.8558 | $3.6239 | -46.53% |
| December, 2025 | $3.4404 | $2.7467 | $4.9276 | -37.33% |
Chromadex Corp Stock (CDXC) Price Forecast for 2026
The predicted value for Chromadex Corp (CDXC) in 2026 is set at an average of $12.95. Estimates vary from a peak of $22.61 to a trough of $3.2914, indicating an +135.87% surge from the present price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.9442 | $3.2914 | $4.1733 | -28.16% |
| February, 2026 | $3.9229 | $3.6379 | $4.937 | -28.54% |
| March, 2026 | $3.6116 | $3.4616 | $4.0688 | -34.21% |
| April, 2026 | $7.2563 | $3.5726 | $7.5463 | +32.17% |
| May, 2026 | $10.85 | $6.8673 | $22.61 | +97.63% |
| June, 2026 | $8.4238 | $7.3519 | $10.89 | +53.44% |
| July, 2026 | $5.8585 | $5.5085 | $8.6047 | +6.71% |
| August, 2026 | $9.2522 | $5.9094 | $9.7422 | +68.53% |
| September, 2026 | $8.4069 | $7.2541 | $9.745 | +53.13% |
| October, 2026 | $7.7106 | $7.1306 | $9.3588 | +40.45% |
| November, 2026 | $7.5044 | $6.6312 | $8.0116 | +36.69% |
| December, 2026 | $5.2587 | $4.1272 | $7.7253 | -4.21% |
Chromadex Corp Stock (CDXC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Chromadex Corp (CDXC) is $3.2428, with a high forecast of $5.9619 and a low forecast of $0.5237. This indicates an -40.93% decrease from the last price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.3728 | $4.7728 | $5.9619 | -2.13% |
| February, 2027 | $4.3765 | $4.3365 | $5.5547 | -20.28% |
| March, 2027 | $3.2112 | $2.9012 | $4.4675 | -41.51% |
| April, 2027 | $2.005 | $1.955 | $3.2021 | -63.48% |
| May, 2027 | $1.4987 | $1.4087 | $2.1259 | -72.70% |
| June, 2027 | $1.5534 | $1.3615 | $2.1634 | -71.71% |
| July, 2027 | $1.4671 | $0.9352 | $1.9962 | -73.28% |
| August, 2027 | $0.9609 | $0.9609 | $1.769 | -82.50% |
| September, 2027 | $0.8155 | $0.5237 | $1.1946 | -85.15% |
| October, 2027 | $0.6593 | $0.6193 | $1.3883 | -87.99% |
| November, 2027 | $0.923 | $0.6521 | $1.3002 | -83.19% |
| December, 2027 | $0.7177 | $0.6658 | $1.1277 | -86.93% |
Chromadex Corp Stock (CDXC) Price Forecast for 2028
In 2028, Chromadex Corp (CDXC) is projected to reach an average price of $0.7386, with a high projection of $1.292 and a low estimate of $0.1852. This indicates an -86.55% fall from the last price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4414 | $0.3939 | $0.8186 | -91.96% |
| February, 2028 | $0.2652 | $0.1852 | $0.5233 | -95.17% |
| March, 2028 | $0.5598 | $0.197 | $0.648 | -89.80% |
| April, 2028 | $0.7436 | $0.5608 | $1.2517 | -86.46% |
| May, 2028 | $0.5483 | $0.4983 | $0.8264 | -90.01% |
| June, 2028 | $0.892 | $0.5092 | $1.292 | -83.75% |
| July, 2028 | $0.9207 | $0.8529 | $1.2439 | -83.23% |
| August, 2028 | $0.5404 | $0.5404 | $1.0504 | -90.16% |
| September, 2028 | $0.5142 | $0.4942 | $0.7614 | -90.63% |
| October, 2028 | $0.4279 | $0.367 | $0.5745 | -92.21% |
| November, 2028 | $0.5926 | $0.4088 | $0.6698 | -89.21% |
| December, 2028 | $0.6463 | $0.5635 | $0.8744 | -88.23% |
Chromadex Corp Stock (CDXC) Price Forecast for 2029
The 2029 price forecast for Chromadex Corp Stock (CDXC) is $2.0567 on average, with a high prediction of $3.7693 and a low estimate of $0.3441. This represents an -62.54% decrease from the previous price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.801 | $0.6109 | $0.8591 | -85.41% |
| February, 2029 | $0.5847 | $0.5347 | $0.8119 | -89.35% |
| March, 2029 | $0.5585 | $0.4885 | $0.6866 | -89.83% |
| April, 2029 | $0.4022 | $0.3922 | $0.6093 | -92.67% |
| May, 2029 | $0.4669 | $0.3441 | $0.7369 | -91.50% |
| June, 2029 | $0.5106 | $0.4197 | $0.6678 | -90.70% |
| July, 2029 | $0.5344 | $0.4225 | $0.6044 | -90.27% |
| August, 2029 | $0.569 | $0.4681 | $0.659 | -89.63% |
| September, 2029 | $0.6328 | $0.57 | $0.7519 | -88.47% |
| October, 2029 | $2.6775 | $0.6237 | $2.7075 | -51.23% |
| November, 2029 | $2.8112 | $2.2884 | $3.7693 | -48.79% |
| December, 2029 | $2.51 | $2.0121 | $2.8421 | -54.28% |
Chromadex Corp Stock (CDXC) Price Forecast for 2030
Chromadex Corp Stock (CDXC) is expected to reach an average price of $1.4727 in 2030, with a high forecast of $2.6519 and a low forecast of $0.2935. This signifies an -73.17% decrease from the last price of $5.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.8094 | $1.5075 | $2.6519 | -67.04% |
| February, 2030 | $2.1068 | $1.4131 | $2.495 | -61.62% |
| March, 2030 | $2.2543 | $1.9587 | $2.5924 | -58.94% |
| April, 2030 | $1.6318 | $1.4618 | $2.2562 | -70.28% |
| May, 2030 | $1.7011 | $1.5937 | $2.0374 | -69.01% |
| June, 2030 | $1.0336 | $0.5649 | $1.683 | -81.17% |
| July, 2030 | $1.363 | $0.4361 | $1.663 | -75.17% |
| August, 2030 | $1.9305 | $1.2199 | $2.4355 | -64.84% |
| September, 2030 | $2.4579 | $1.9173 | $2.5729 | -55.23% |
| October, 2030 | $1.8973 | $1.7201 | $2.4648 | -65.44% |
| November, 2030 | $1.1398 | $0.8698 | $1.9542 | -79.24% |
| December, 2030 | $1.0273 | $0.2935 | $1.1716 | -81.29% |
2.20%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):